PC–CARE Act

The PC-CARE Act, also known as Bill 118 hr 1315, is a piece of legislation currently being considered by the US Congress. The purpose of this bill is to address the issue of patient access to affordable prescription medications.

The PC-CARE Act aims to achieve this goal by implementing several key provisions. First, the bill seeks to increase transparency in drug pricing by requiring pharmaceutical companies to disclose the costs associated with producing and marketing their medications. This information would then be made available to the public, allowing patients to make more informed decisions about their healthcare options.

Additionally, the PC-CARE Act includes measures to promote competition in the pharmaceutical industry. This includes provisions to prevent drug manufacturers from engaging in anti-competitive practices, such as pay-for-delay agreements that delay the entry of generic medications into the market. Furthermore, the bill seeks to expand access to affordable prescription drugs by allowing for the importation of safe and affordable medications from other countries. This provision is intended to provide patients with more options for obtaining their necessary medications at a lower cost. Overall, the PC-CARE Act is aimed at addressing the issue of rising prescription drug prices and ensuring that patients have access to the medications they need at an affordable price. It is currently being debated in Congress, with supporters arguing that it will help lower healthcare costs for Americans, while opponents raise concerns about potential impacts on the pharmaceutical industry.